Litcius/Paper detail

Targeting transforming growth factor-β2 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancer

Hong Kyu Lee, Hyeong-Jin Ji, Sang-Kyung Shin, Jihye Koo, Tae Hun Kim, Cho‐Won Kim, Yeon Hee Seong, Jun-Eui Park, Kyung‐Chul Choi

2022Cancer Immunology Immunotherapy13 citationsDOIOpen Access PDF

Topics & Concepts

Cytotoxic T cellGranzymeCancer researchTransforming growth factorGranzyme BCD8FOXP3Immune systemBiologyTransforming growth factor betaImmunologyChemistryPerforinCell biologyIn vitroBiochemistryCancer Immunotherapy and BiomarkersCytokine Signaling Pathways and InteractionsCancer Cells and Metastasis
Targeting transforming growth factor-β2 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancer | Litcius